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Abstract 
Purpose: To evaluate the cytotoxic, anti-inflammatory and antioxidant activities of four different solvent 
extracts obtained from the aerial parts of Galega officinalis L. 
Methods:  The hexane, DCM, methanol and water extracts of G. officinalis were successively obtained 
by soxhlet extraction method. The cytotoxic activity of the extracts was assessed against human lung 
carcinoma (A-549), human colorectal adenocarcinoma (HT-29), human brain glioblastoma (U-87), and 
colon adenocarcinoma (DLD-1) by Resazurine test. The antioxidant activity of extracts were determined 
by Folin-Ciocalteau, oxygen radical absorbing capacity (ORAC), and 2’.7’-dichlorofluorescin-diacetate 
(DCFH-DA) cell-based assay while their anti-inflammatory activity was determined by nitric oxide (NO) 
assay.   
Results: DCM extract showed strong cytotoxic activity against lung adenocarcinoma and brain 
glioblastoma cell lines, with IC50 (concentration inhibiting 50 % of cell growth) values of 11 ± 0.4 and 16 
± 3 µg/mL, respectively. The hexane extract showed moderate anticancer activity against the same cell 
lines (59 ± 13 and 63 ± 16 µg/mL, respectively). DCM extract also showed significant anti-inflammatory 
activity, inhibiting NO release by 86.7 % at 40 µg/mL in lipopolysaccharide (LPS) - stimulated murine 
RAW 264.7 macrophages. Of all test extracts, the methanol extract of G. officinalis showed the highest 
antioxidant activity with 2.33 ± 0.09 µmol Trolox/mg , 7.10 ± 0.9 g tannic acid equivalent (TAE), and IC50 
of 44 ± 4 µg/mL.  
Conclusion: The findings of this study suggest that DCM extract may possess anticancer effect against 
lung adenocarcinoma and brain glioblastoma, as well as serve as an anti-inflammatory agent. 
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Galega officinalis L., which belongs to 
Leguminosae family, is generally known as 
goat’s rue and is a native plant in Southeastern 
Europe, Middle East, and Western Asia. It grows 
wild in damp and low-lying areas [1,2]. Aerial 
parts of this crop is widely used as a functional 
remedy against malignant fever, inflammation, 
parasitic infection, worms, and diabetes in 
Europe [3,4]. It has also been used to increase 
breast milk production in folk medicine [5,6]. This 
plant was described as a diuretic [3] and anti-
diabetic crop, having the capacity to reduce 
blood sugar levels [3,7]. Goat rue contains some 
secondary metabolites such as alkaloids 
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(including galegine), saponins, flavonoids 
(flavonol triglycosides, kaempferol, and 
quercetin) [14], tannins [3] and fatty acids (α-
linolenic acid, palmitic acid and linoleic acid) [15] 
and phytoestrogens (medicarpin, and sativan) 
[15,16]. Galegine, a compound isolated from 
leaves of G. officinalis [3] and metformin, a 
synthetic form of galegine reduce blood sugar 
levels and find in many anti-diabetic drugs as an 
active molecule [7-9]. 
 
Atanasov and Spasov [10] have shown that the 
aqueous extract and the gel-filtered fractions 
from the G. officinalis have inhibitory activity on 
platelet aggregation. The antibacterial activities 
of G. officinalis have been shown against to 
Gram positive (Staphylococcus aureus and 
Staphylococcus epidermidis) and gram-negative 
(Serratia marcescens, Salmonella typhimurium, 
Pseudomonas aeruginosa, Proteus vulgaris and 
Eschericia coli) bacteria [2,12]. There are also 
some studies demonstrating toxicity of aerial 
parts of G. officinalis in sheep [12,13] and in rats 
[6]. 
 
The present study was carried out to evaluate 
the cytotoxic, anti-inflammatory, and antioxidant 
activities of four different fractions obtained from 




Plant material and extraction procedure 
 
The aerial parts of the goat rue (Galega 
officinalis L.) were obtained from Abant Izzet 
Baysal University Campus, Bolu, Turkey in July. 
Recognition of the  plant species was carried out 
by Prof. Dr. Arzu Ucar Turker using “Flora of 
Turkey and the East Aegean Islands” [1], and a 
voucher specimen (collection no. AUT-1912) was 
kept at the Abant Izzet Baysal University (AIBU) 
Herbarium, Bolu, Turkey. 
 
The collected plant materials were cleaned and 
oven dried at 40 oC for seven days. The dried 
aerial parts of G. officinalis were powdered and 
100 g dried weight of plant material was 
successively extracted with 800 mL hexane (at 
65 - 70 oC), 600 mL dichloromethane (at 55 - 60 
oC), 600 mL methanol (at 60 oC) and 300 mL 
water (at 80 oC) by using soxhlet apparatus for 
18 hrs.  The four different fractions of G. 
officinalis were filtered with Whatmann No 1 filter 
paper. The fraction solvents were concentrated 
by a rotary evaporator under low vacuum at 40 
oC to dryness. The yield of the extracts (w/w) 
were 1.9 % for hexane, 0.38 % for DCM, 10.2 % 
for MeOH and 10.36 % for water fractions. The 
dried extracts were stored in the dark at -20 oC. 
For biological activity assays, the crude extracts 
were dissolved in sterile dimethyl sulfoxide 
(DMSO) in order to obtain a final concentration of 
80 mg/mL.  
 
Cell lines and culture conditions  
 
Human lung carcinoma A-549, human colorectal 
adenocarcinoma HT-29,  human brain 
glioblastoma U-87, colon adenocarcinoma DLD-
1, normal skin fibroblast WS1 and murine 
macrophage RAW 264.7 cell lines were provided 
from the American Type Culture Collection 
(ATCC, Manassas, VA, USA). The used cell lines 
were augmented in Dulbecco’s minimum 
essential medium (DMEM) with Earle’s salts 
(Mediatech Cellgro, Herndon, USA),which was 
completed with 10 % fetal bovine serum (FBS; 
Hyclone, Logan, USA), a solution of vitamins, 
sodium pyruvate and non-essential amino acids 
(all at 1:100 v/v dilution of supplied solutions), 
streptomycin (100 µg/ mL), and penicillin (100 
IU/mL) (Mediatech Cellgro, VA). A humidified 
atmosphere at 37 °C in 5 % CO2 was available 
for incubation of all cells.  
 
Screening for cytotoxic activity  
 
Growing cells were exponentially located in 96-
well microplates (Costar, Corning Inc.) at a 
density of 5 × 103 cells per well in 100 µL of 
culture medium and were led to adhere for 16 h 
before application. All G. officinalis extracts were 
made in a series of eight two fold dilutions (0 – 
200 µg/mL). Then, 100 µL of raising levels of 
tested extracts were put into to three wells. The 
highest level of DMSO in the culture medium was 
sustained at 0.5 % (v/v) to eliminate solvent 
toxicity. The cell cultures were cultured for 48 h 
in the presence or absence of G. officinalis 
extracts. Etoposide (≥ 98 %, Sigma–Aldrich) was 
utilized as a positive control for the relevant 
comparison. The resazurin reduction test was 
used to detect the cell viability [17]. Fluorescence 
was read for the metabolic activity of cells in 
each well by Fluoroskan Ascent FL Thermo plate 
reader (Labsystem). Survival percentages of 
cells were detected as the fluorescence in 
experimental wells compared to that in control 
wells after subtraction of blank values. After 
reading the resazurin test, cells were treated for 
cellular DNA assay with Hoechst dye 33342. 
After washing with PBS solution, dried cells were 
kept at -80 °C until the Hoechst assay was 
carried out [18]. Cytotoxicity data were 
represented by using means ± standard 
deviation and expressed by the concentration 
that inhibited 50 % of cell growth (IC50). Each 
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concentration of four different extracts from G. 
officinalis was measured three times. 
 
Determination of anti-inflammatory activity  
 
Growing cells were exponentially plated at a 
density of 75 × 103 cells per well in 96-well 
microplates (BD Falcon) in 100 µL of cell culture 
medium and were allowed to cohere overnight. 
Each G. officinalis extract was made in a series 
of 8 two fold dilutions (final concentrations 
ranging from 0 to 160 µg/mL) in DMSO and 
medium culture. The cells were either applied or 
not with positive control N(G)-nitro-L-arginine 
methyl ester hydrochloride (L-NAME, ≥ 98 %, 
Sigma–Aldrich), or raising levels of G. officinalis 
extracts on 3 wells.  
 
Tested cells were then induced with 100 µg/mL 
of LPS and cultured at 37 °C, 5 % CO2 for 24 h. 
After 24 h, cell-free supernatants were gathered 
and NO level was instantly detected by means of 
the Griess reaction with a small amount of 
modifications [19]. Furthermore, 100 µL aliquots 
of cell supernatants were cultured with an equal 
volume of Griss reagent (50 µL of 1 % 
sulfanilamide in 2.5 % H3PO4 and 50 µL of 0.1 % 
N-1-naphtyl-ethylenediamine dihydrochloride in 
water) at 22 ± 2 °C for 20 min. Absorbance at 
550 nm was then determined via an automated 
96-well Varioskan Ascent plate reader (Thermo 
Electron) and the presence of nitrite was 
measured by comparison with sodium nitrite 
(NaNO2) standard curve. Macrophage survival 
was measured by means of the resazurin 
reduction test. 
 
Assessment of oxygen radical absorbing 
capacity (ORACFL) assay 
 
The antioxidant properties of G. officinalis 
extracts were determined by using oxygen 
radical absorbance capacity (ORAC) assay that 
detects their scavenging capacity against peroxyl 
radicals. The experimental method was modified 
from the process defined by Ou et al [20]. 
Shortly, the ORAC assay was made using 96-
wells microplates and a Fluoroskan Ascent FlTM 
microplate reader (Labsystems, Milford, MA, 
USA). A positive control standard was trolox, a 
water-soluble analog of vitamin E.  
 
The study was managed at 37.5 °C and pH 7.4 
with a blank sample. The final data were 
determined by calculating the net areas under 
the fluorescein decay curves between the blank 
and the treatments. ORAC values were 
represented in µmol of Trolox equivalents/mg dry 
weight of sample (µmol TE/mg dw). 
 
Total phenolic assay  
 
The total phenolic content was analyzed by using 
the Folin-Ciocalteu reagent according to the 
procedure reported by Singleton and Rossi [21]. 
The experiment was performed 3 times, and the 
data were represented in g TAE/100 g dried 
mass. 
 
Antioxidant cell assay  
 
The antioxidant activity was also performed using 
the 2′,7′-dichlorofluorescin-diacetate (DCFH-DA) 
assay as defined by Girard-Lalancette et al [22], 
with some minor changes. Growing WS1 cells 
were exponentially plated in 96-wells microplates 
at 10 × 103 cells per well and maintened for one 
day at 37.5 °C and 5 % CO2. The WS1 cells 
were rinsed with 150  µL Hank’s balanced salt 
solution (HBSS) at pH 7.4 and cultured for 30 
min with 100  µL HBSS (pH 7.4) including 5  µM 
DCFH-DA (Sigma–Aldrich). The WS1 cells were 
rinsed again with 150 µL HBSS. To evaluate the 
cellular antioxidant activity, the cells were 
cultured either with an increasing level   of four 
different extracts from G. officinalis, quercetin or 
trolox, in the absence or presence of 200 µM tert 
-butylhydroperoxide (t- BuOOH). After t- BuOOH 
treatment, fluorescence was determined 
instantly. Again 90 min later, it was read by using 
an automated 96-well plate reader (Fluoroskan 
Ascent Fl, Thermo-Labsystems) at an excitation 
wavelength of 485 nm and an emission 




Data were presented as mean ± SD and 
analyzed using SPSS software (version 22.0, 
SPSS Inc, Chicago, IL, USA) for Windows by 
one-way ANOVA using Duncan’s Multiple Range 
Tests. Differences were considered statistically 




The results for antiproliferative activities of four 
different extracts from G. officinalis against A-
549, HT-29, U-87, DLD-1, and WS1 cell lines 
were represented in Table 1. In this experiment, 
DCM and hexane extracts were found to display 
from strong to moderate cytotoxicities when IC50 
values were between 11 and 100 µg/mL. DCM 
extract of G. officinalis showed the highest 
cytotoxic activity against to A-549 (11 ± 0.4 
µg/mL) and U-87 (16 ± 3 µg/mL) cancer cell lines 
(Table 1). The hexane extract showed a 
moderate anti-cancer activity against to A-549 
and U-87 cell lines, with IC50 values of 59 ± 1 and 
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63 ± 16 µg/mL, respectively (Table 1). However, 
the MeOH and water extracts were inactive 
against to A-549, HT-29, U-87, and DLD-1 with 
an IC50 value higher than 100 µg/mL (Table 1). 
 
The anti-inflammatory activity of the extracts was 
observed by assessing their ability to prevent 
cellular NO production, which is an endogenous 
free radical species. As shown in Figure 1, the 
DCM extract showed stronger inhibitory effect on 
LPS-induced NO secretion with 86.7 % inhibition 
than hexane (52.9 % inhibition), methanol (17.8 
% inhibition) and water (16.2 % inhibition) 
extracts of G. officinalis observed at 40 µg/mL 
concentration. Relatively, the L-NAME prevented 
NO release by 63.9 % at 250.0 μM (67.4 μg/mL). 
The anti-inflammatory properties were evaluated 
at non-cytotoxic concentrations. To investigate 
the effects of G. officinalis extracts on the viability 
of murine macrophages (RAW 264), we carried 
out resazurin assay. When we treated with the 
extracts at concentrations of 1.25, 2.5, 5, 10, 20, 
40, 80, 100 µg/mL, it had no effect on cell 
viability. 
 
The incubation of murine macrophages with G. 
officinalis extracts and 10 μg/mL LPS also did 
not show any cytotoxicity (data not shown). 
 
In Table 2, the current findings demonstrated that 
the MeOH and water extracts were moderate 
antioxidant, with ORAC values of 2.33 ± 0.09 and 
1.85 ± 0.12 µmol TE/mg of dry weight, 
respectively. The hexane and DCM extracts were 
low antioxidant, with ORAC values, respectively, 
of 0.14 ± 0.00 and 0.48 ± 0.03 µmol TE/mg of dry 
mass. The ORAC value of standard phenolic 
compound used as a positive control (quercetine) 
was 19.20 ± 0.80 µmol TE/mg (Table 2). 
 
Table 1. In vitro cytotoxic activities of four different extracts (hexane, DCM, MeOH and water) of aerial parts of 
Galega officinalis against A-549, HT-29, U-87, DLD-1 and WS1 cell lines 
 
Treatment IC50 (µg/mL for extracts, µM for etoposide) A-549a HT-29b U-87c DLD-1d WS1e 
Hexane  59 ± 13  >100g  63 ± 16  >100g   97 ± 12  
Dichloromethane 11.1 ± 0.4 77 ± 29  16 ± 3  >100g  32 ± 5  
Methanol >200  >200  >200  >200  >200  
Water >200 >200  >200  >200  >200  
Etoposidef 4.5 ± 0.3  >100h 98 ± 32 6.0 ± 0.7  >100h  
Note: Mean values (± standart deviation) for triplicate assays. a A549, human lung carcinoma cell line. b HT-29, 
human colorectal adenocarcinoma cell line. c U-87, human brain glioblastoma cell line. d DLD-1, human colorectal 
adenocarcinoma cell line. e WS1, human normal skin fibroblasts cell line. f Positive control. g An extract was 
considered inactive when IC50 is over than 100 µg/mL [23].h A pure compound was considered inactive when IC50 





























Figure 1: Effects of Galega officinalis extracts (40.0 µg/ml) and L-NAME (250 µM) on NO production in LPS-
stimulated RAW-264.7 macrophages. Results were represented as mean ± S.D of three replications 
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Table 2: Antioxidant activities of four different extracts of Galega officinalis using ORAC, Folin-Ciocalteu, and 
cell-based assays 
 
Sample ORAC assay Folin-Ciocalteu Cell-based assay µmol Trolox / mg Phenolics % w/w WS1 IC50 (µg/mL)a 
Hexane extract 0.14 ± 0.01 0.50 ± 0.2  67 ± 9 
DCM extract 0.48 ± 0.03 2.40 ± 1.2  65 ± 5 
MeOH extract 2.33 ± 0.09 7.10 ± 0.9  44 ± 4 
Water extract 1.85 ± 0.12 6.70 ± 0.8  70 ± 8 
Quercetine 19.2 ± 0.80 nd 2.5 ± 0.2 
Trolox nd nd 1.5 ± 0.5 
Tannic Acid nd 93.1 ± 30.6  nd 
Mean values (± standard deviation) are for triplicate assays; nd not determined; a Concentration inhibiting DCFH 
oxidation induced by t- BuOOH by 50 percent 
 
The data for the total phenolic content (Table 2) 
showed that the MeOH and water extracts of G. 
officinalis had low levels of phenolic contents 
(7.10 ± 0.9 and 6.70 ± 0.8 g TAE/100 g of 
extract, respectively). Similarly, the hexane (0.50 
± 0.2 TAE/100 g) and DCM (2.40 ± 1.2 g 
TAE/100 g) extracts contained low concentration 
of phenolic compounds. 
 
The cell-based assay results (expressed as IC50) 
of t-BuOOH-induced oxidation of 2′,7′-
dichlorofluorescin (DCFH) indicate that quercetin 
and trolox, used as positive controls, had IC50 of 
2.5 ± 0.2 and 1.5 ± 0.5 μg/mL, respectively 
(Table 2). Hexane (67 ± 9 µg/mL), DCM (65 ± 5 
µg/mL), MeOH (44 ± 4 µg/mL), and water (70 ± 8 
µg/mL) extracts prevented tBH-induced oxidation 




The DCM extract of G. officinalis has promising 
anticancer activity against A549, HT-29, and U-
87 with IC50 < 100 µg/mL. An extract is accepted 
as active against cancer cell lines when IC50 
value is < 100 µg/mL [23,24]. The anticancer 
activity of DCM and hexane extracts can be 
attributed to the alkaloids (galegine) or flavonoids 
(kaempferol, quercetin, medicarpin and sativan) 
found as dominant substances in goat rue [14]. 
According to one study [14], sativan and 
medicarpin as phytoestrogens isolated from the 
leaves of goat rue were found to be cytotoxic 
against human breast cancer cell lines. Morever, 
the anti-mutagenic, anti-inflammatory, anti-viral, 
and anti-carcinogenic activities of phytoestrogens 
have also been demonstrated formerly [14]. 
 
Although the aerial parts of G. officinalis have 
been widely used for the treatment of 
inflammatory diseases in traditional medicine [3-
4], the anti-inflammatory activity of this medicinal 
plant has not been scientifically verified up to 
now. This is the first report about the anti-
inflammatory activity of G. officinalis. Nitrit oxide 
(NO) is an important regulator of body 
homeostasis in animals and high amounts of NO 
causes many serious inflammatory diseases [25]. 
For this reason, prevention of NO generation 
may be an effective approach for the remedy of 
various inflammatory diseases [25]. The anti-
inflammatory activity of the extracts was 
considered using LPS-induced RAW 264.7 
macrophages. L –NAME was used as a positive 
control, because it inhibits the formation of NO in 
LPS-stimulated murine RAW 264.7 macrophages 
[26]. A prerequisite for anti-inflammatory studies 
is that the extract or substance being tested 
should not have cytotoxic activity toward murine 
macrophage RAW 264.7 cells. Inhibition of NO 
secretion in murine macrophage RAW 264.7 
cells is caused by two effects: by anti-
inflammatory property or decreasing the cell 
viability of the murine macrophages [19]. Figure 
2 indicated that the inhibition rates of NO 
production by the DCM extract of G. officinalis 
was 86.7 % at the concentration of 40 μg/mL. 
The cell viability data represents the strong 
inhibitory effect of the DCM extract on NO 
secretion is not due to its cytotoxicity (data not 
shown). The strong anti-inflammatory activity of 
the DCM extract of G. officinalis may be 
attributed to the alkaloid or flavonoid constituents 
of this plant [14]. 
 
The antioxidant activities (in vitro and ex vivo) of 
different G. officinalis extracts have not been 
previously investigated in the literature. Among 
the tested extracts, MeOH extract had the best 
phenolic content, ORAC value, and IC50 value in 
cell-based assay. The revealed antioxidant 
activity can be explained by the presence of 
some phenolic substances in the extract 
ingredient. Although DCM extract had the best 
anticancer and anti-inflammatory activities, it 
includes low amounts of trolox and total phenolic 
content. At the same time, hexane extract 
showed potent anticancer activity against A549 
and U-87 (IC50 of 59 ± 13 µg/mL and 63 ± 16 
µg/mL), and anti-inflammatory activity on LPS-
induced NO secretion with 52.9 % inhibition at 40 
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µg/mL concentration. This is possibly due to the 
presence of some specific phenolic compounds, 
terpenoids or alkaloids in the DCM and hexane 
extracts. The various amount of secondary 
metabolites present in G. officinalis extracts 
could be explained by the different polarity of the 
extraction solvents (hexane, DCM, methanol, 




The anticancer, anti-inflammatory, and 
antioxidant activities for four different solvent 
extracts from Galega officinalis revealed that the 
DCM and hexane extracts from the aerial parts 
were active against human lung and brain 
glioblastoma carcinoma cell lines. DCM extract 
also exhibited remarkable anti-inflammatory 
activity. On the basis of the findings of this study, 
there seems to be some justification for the use 
of the aerial parts of G. officinalis in traditional 
medicine as an anti-inflammatory agent. Future 
studies are required to isolate the chemical 
constituents and to estimate the inhibitory effect 
of individual compounds of G. officinalis on 
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